Advanced Biomedical Technologies Inc
Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for… Read more
Advanced Biomedical Technologies Inc (ABMT) - Net Assets
Latest net assets as of July 2022: $-8.32 Million USD
Based on the latest financial reports, Advanced Biomedical Technologies Inc (ABMT) has net assets worth $-8.32 Million USD as of July 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($383.49K) and total liabilities ($8.70 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-8.32 Million |
| % of Total Assets | -2168.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Advanced Biomedical Technologies Inc - Net Assets Trend (2006–2022)
This chart illustrates how Advanced Biomedical Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Advanced Biomedical Technologies Inc (2006–2022)
The table below shows the annual net assets of Advanced Biomedical Technologies Inc from 2006 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-10-31 | $-7.94 Million | +5.34% |
| 2021-10-31 | $-8.38 Million | -13.27% |
| 2020-10-31 | $-7.40 Million | -14.26% |
| 2019-10-31 | $-6.48 Million | -15.29% |
| 2018-10-31 | $-5.62 Million | -12.49% |
| 2017-10-31 | $-5.00 Million | -14.50% |
| 2016-10-31 | $-4.36 Million | +2.22% |
| 2015-10-31 | $-4.46 Million | -19.34% |
| 2014-10-31 | $-3.74 Million | -27.40% |
| 2013-10-31 | $-2.93 Million | -31.81% |
| 2012-10-31 | $-2.23 Million | -42.45% |
| 2011-10-31 | $-1.56 Million | -4.85% |
| 2010-10-31 | $-1.49 Million | -18.04% |
| 2009-10-31 | $-1.26 Million | -68.27% |
| 2008-10-31 | $-750.42K | -10672.33% |
| 2007-10-31 | $7.10K | +156.40% |
| 2006-10-31 | $-12.58K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Advanced Biomedical Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1098820600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (October 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $709.00 | % |
| Other Comprehensive Income | $661.17K | % |
| Other Components | $2.90 Million | % |
| Total Equity | $-7.94 Million | 100.00% |
Advanced Biomedical Technologies Inc Competitors by Market Cap
The table below lists competitors of Advanced Biomedical Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vitruvia Medical AG
MU:991
|
$14.18K |
|
Kairous Acquisition Corp. Limited Warrants
NASDAQ:KACLW
|
$14.19K |
|
Agriculture Printing and Packaging JSC
VN:INN
|
$14.21K |
|
Colombo Investment Trust PLC
CM:CITN0000
|
$14.24K |
|
GreenBank Capital Inc
PINK:GRNBF
|
$14.18K |
|
OPCT3F
SA:OPCT3F
|
$14.15K |
|
BIOSTIME INTL
BE:8BI
|
$14.15K |
|
HAPV3F
SA:HAPV3F
|
$14.15K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Advanced Biomedical Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -8,384,174 to -7,936,431, a change of 447,743.
- Net loss of 515,485 reduced equity.
- Other comprehensive income increased equity by 931,278.
- Other factors increased equity by 31,950.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-515.49K | -6.5% |
| Other Comprehensive Income | $931.28K | +11.73% |
| Other Changes | $31.95K | +0.4% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Advanced Biomedical Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-10-31 | $0.00 | $0.00 | x |
| 2007-10-31 | $0.00 | $0.00 | x |
| 2008-10-31 | $-0.01 | $0.00 | x |
| 2009-10-31 | $-0.02 | $0.00 | x |
| 2010-10-31 | $-0.03 | $0.00 | x |
| 2011-10-31 | $-0.03 | $0.00 | x |
| 2012-10-31 | $-0.04 | $0.00 | x |
| 2013-10-31 | $-0.05 | $0.00 | x |
| 2014-10-31 | $-0.07 | $0.00 | x |
| 2015-10-31 | $-0.08 | $0.00 | x |
| 2016-10-31 | $-0.07 | $0.00 | x |
| 2017-10-31 | $-0.07 | $0.00 | x |
| 2018-10-31 | $-0.08 | $0.00 | x |
| 2019-10-31 | $-0.09 | $0.00 | x |
| 2020-10-31 | $-0.11 | $0.00 | x |
| 2021-10-31 | $-0.12 | $0.00 | x |
| 2022-10-31 | $-0.11 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Advanced Biomedical Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -190.22%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-31.04%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-511.83K |
| 2007 | -527.74% | 0.00% | 0.00x | 1.32x | $-38.17K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-154.96K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-432.16K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-667.75K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-331.16K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-535.91K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-596.90K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-453.90K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-416.71K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-288.51K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-192.10K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-391.42K |
| 2019 | 0.00% | -8139.49% | 0.05x | 0.00x | $-301.00K |
| 2020 | 0.00% | -543.75% | 0.26x | 0.00x | $68.18K |
| 2021 | 0.00% | -426.10% | 0.38x | 0.00x | $108.98K |
| 2022 | 0.00% | -190.22% | 0.68x | 0.00x | $278.16K |
Industry Comparison
This section compares Advanced Biomedical Technologies Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $772,439,671
- Average return on equity (ROE) among peers: -28.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Advanced Biomedical Technologies Inc (ABMT) | $-8.32 Million | 0.00% | N/A | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |